Dear all,
We have one case in which subject has abnormal blood pressure before dosing of period-1. So this subject was not dosed. Is it require to open adverse event for this subject and report it in the final report? or is it ok if we mention (in subject screening record) that this subject didn't meet pre-dosing requirement and was withdrawn.
kindly let me know your thoughts.